Response monitoring in metastatic breast Cancer: a prospective study comparing 18F-FDG PET/CT with conventional CT
M Vogsen, F Harbo, NM Jakobsen… - Journal of Nuclear …, 2023 - Soc Nuclear Med
This study aimed to compare contrast-enhanced CT (CE-CT) and 18F-FDG PET/CT for
response monitoring in metastatic breast cancer using the standardized response …
response monitoring in metastatic breast cancer using the standardized response …
Comparison of FDG-PET/CT and contrast-enhanced CT for monitoring therapy response in patients with metastatic breast cancer
Purpose The aim of this study was to compare fluorodeoxyglucose positron emission
tomography/computed tomography (FDG PET/CT) and contrast-enhanced computed …
tomography/computed tomography (FDG PET/CT) and contrast-enhanced computed …
[HTML][HTML] 2-[18F]FDG-PET/CT is a better predictor of survival than conventional CT: a prospective study of response monitoring in metastatic breast cancer
M Vogsen, M Naghavi-Behzad, FG Harbo… - Scientific Reports, 2023 - nature.com
This study aimed to compare CE-CT and 2-[18F] FDG-PET/CT for response monitoring
metastatic breast cancer (MBC). The primary objective was to predict progression-free and …
metastatic breast cancer (MBC). The primary objective was to predict progression-free and …
[HTML][HTML] FDG-PET/CT versus contrast-enhanced CT for response evaluation in metastatic breast cancer: a systematic review
18F-fluorodeoxyglucose positron emission tomography with integrated computed
tomography (FDG-PET/CT) and contrast-enhanced computed tomography (CT) can be used …
tomography (FDG-PET/CT) and contrast-enhanced computed tomography (CT) can be used …
[HTML][HTML] FDG-PET/CT for response monitoring in metastatic breast cancer: Today, tomorrow, and beyond
MG Hildebrandt, JF Lauridsen, M Vogsen, J Holm… - Cancers, 2019 - mdpi.com
While current international guidelines include imaging of the target lesion for response
monitoring in metastatic breast cancer, they do not provide specific recommendations for …
monitoring in metastatic breast cancer, they do not provide specific recommendations for …
[HTML][HTML] Clinical impact of FDG-PET/CT compared with CE-CT in response monitoring of metastatic breast cancer
M Naghavi-Behzad, HR Oltmann, TA Alamdari… - Cancers, 2021 - mdpi.com
Simple Summary The method of treatment evaluation in patients with chronic breast cancer
may affect clinical decision making and treatment protocols. In this study, we compared the …
may affect clinical decision making and treatment protocols. In this study, we compared the …
[HTML][HTML] Interrater agreement and reliability of PERCIST and visual assessment when using 18F-FDG-PET/CT for response monitoring of metastatic breast cancer
JS Sørensen, MH Vilstrup, J Holm, M Vogsen, JL Bülow… - Diagnostics, 2020 - mdpi.com
Response evaluation at regular intervals is indicated for treatment of metastatic breast
cancer (MBC). FDG-PET/CT has the potential to monitor treatment response accurately. Our …
cancer (MBC). FDG-PET/CT has the potential to monitor treatment response accurately. Our …
[HTML][HTML] FDG-PET/CT for response monitoring in metastatic breast cancer: the feasibility and benefits of applying PERCIST
M Vogsen, JL Bülow, L Ljungstrøm, HR Oltmann… - Diagnostics, 2021 - mdpi.com
Background: We aimed to examine the feasibility and potential benefit of applying PET
Response Criteria in Solid Tumors (PERCIST) for response monitoring in metastatic breast …
Response Criteria in Solid Tumors (PERCIST) for response monitoring in metastatic breast …
[HTML][HTML] A role of FDG-PET/CT for response evaluation in metastatic breast cancer?
MG Hildebrandt, M Naghavi-Behzad… - Seminars in Nuclear …, 2022 - Elsevier
Breast cancer prognosis is steadily improving due to early detection of primary cancer in
screening programs and revolutionizing treatment development. In the metastatic setting …
screening programs and revolutionizing treatment development. In the metastatic setting …
The impact that number of analyzed metastatic breast cancer lesions has on response assessment by 18F-FDG PET/CT using PERCIST
The PET Response Criteria in Solid Tumors (PERCIST) are not specific regarding the
number of lesions that should be analyzed per patient. This study evaluated how the number …
number of lesions that should be analyzed per patient. This study evaluated how the number …
相关搜索
- breast cancer fdg pet
- breast cancer response monitoring
- response monitoring fdg pet
- response monitoring visual assessment
- visual assessment fdg pet
- breast cancer visual assessment
- response monitoring survival times
- response monitoring clinical impact
- response monitoring feasibility and benefits
- feasibility and benefits fdg pet
- survival times fdg pet
- clinical impact fdg pet
- breast cancer feasibility and benefits
- breast cancer survival times
- breast cancer clinical impact
- response monitoring interrater agreement